UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011062 |
|---|---|
| Receipt number | R000012944 |
| Scientific Title | Phase I study of neoadjuvant chemotherapy with gemcitabine and nab paclitaxel for resectable pancreatic cancer. |
| Date of disclosure of the study information | 2013/07/01 |
| Last modified on | 2021/01/03 12:34:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/06/28 11:06:20 | ||
| 2 | Update | 2013/08/30 13:21:49 | Email Address Address |
|
| 3 | Update | 2013/08/30 13:23:13 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2016/06/28 10:57:18 | Division name Division name Name of primary person or sponsor Institute Institute Organization |
|
| 5 | Update | 2019/07/03 09:48:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Nationality of Funding Organization Address2 Tel2 Email2 Address3 Tel3 Email3 Organization Organization Address Address Tel |
|
| 6 | Update | 2019/07/03 09:54:08 | Date of IRB Last follow-up date Date of closure to data entry |
|
| 7 | Update | 2021/01/03 12:23:09 | Recruitment status |
|
| 8 | Update | 2021/01/03 12:34:51 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
